Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.4184
+0.0312 (8.06%)
At close: Nov 13, 2026, 4:00 PM EST
0.4252
+0.0068 (1.63%)
After-hours: Nov 13, 2026, 7:47 PM EST

Ensysce Biosciences Revenue

Ensysce Biosciences had revenue of $2.18M in the quarter ending September 30, 2026, with 342.43% growth. This brings the company's total for the last twelve months to $6.19M, up 37.91% year-over-year. In the year 2025, Ensysce Biosciences had annual revenue of $5.07M, down -2.75%. That makes Ensysce Biosciences the 39,297th largest company in the world by revenue and 5,192nd in the United States.

Revenue (ttm)
$6.19M
Revenue Growth
+37.91%
P/S Ratio
1.32
Revenue / Employee
$618,928
Employees
10
Market Cap
8.14M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20255.07M-143.38K-2.75%
Dec 31, 20245.21M2.98M133.58%
Dec 31, 20232.23M-292.86K-11.61%
Dec 31, 20222.52M-1.01M-28.54%
Dec 31, 20213.53M-400.01K-10.18%
Dec 31, 20203.93M--
Dec 31, 2019---
Dec 31, 2018---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.